Inogen | INGN - Ebit


Inogen reported $-13.83M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Accuray USD 11.38M 12.71M Sep/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Chart Industries USD 177.5M 8M Sep/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Philips EUR 719M 390M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025